Analysis of COVID-19 clinical course among vaccinated against SARS-CoV-2 people in the Khabarovsk krai
-
Published:2022-09-22
Issue:85
Volume:
Page:19-25
-
ISSN:1998-5029
-
Container-title:Bulletin Physiology and Pathology of Respiration
-
language:
-
Short-container-title:Bûlletenʹ fiziologii i patologii dyhaniâ
Author:
Bazykina E. A.1ORCID, Trotsenko O. E.1, Zaitseva T. A.2, Karavyanskaya T. N.2
Affiliation:
1. Khabarovsk Research Institute of Epidemiology and Microbiology of Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) 2. Khabarovsk Krai Regional Office of Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
Abstract
Aim. To analyze clinical manifestations of novel coronavirus infection among vaccinated population of the Khabarovsk krai with breakthrough infection.Materials and methods. Analysis was based on official data including information on COVID-19 breakthrough infections provided by Khabarovsk krai Rospotrebnadzor regional office. Statistical analysis included calculation of Spearman's rank correlation, odds ratio.Results. A relatively small proportion (0.7%) of breakthrough COVID-cases that occurred among Khabarovsk residents vaccinated against SARS-CoV-2 was shown during analyzed period of time. The highest risk of contracting COVID-19 was revealed among people aged over 50 years. Course of breakthrough COVID-19 infection was mostly mild ‒ 61.0% (95% CI: 54.2‒67.6%). In most cases COVID-19 manifested itself as acute respiratory viral infection ‒ 66.7% (95% CI: 60.0‒73.0%). A significant negative correlation was noted between levels of blood saturation and duration of the disease (ρ=-0.82; p<0.05). Duration of COVID- 19 among vaccinated people was 16 days in for patients treated in an outpatient facility and 17 days for hospitalized patients in average. Most common clinical manifestations of COVID-19, noted by more than half of the respondents, were hyperthermia ‒ 55.7% (95% CI: 48.8–62.5%), weakness and cough ‒ 65.7% each (95% CI: 59.1–72,2%).Conclusion. Obtained data testify in favor of significant protective potential of vaccines against COVID-19.
Publisher
Far Eastern Scientific Center Of Physiology and Pathology of Respiration
Reference10 articles.
1. Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V., Tukhvatulin A.I., Zubkova O.V., Dzharullaeva A.S., Kovyrshina A.V., Lubenets N.L., Grousova D.M., Erokhova A.S., Botikov A.G., Izhaeva F.M., Popova O., Ozharovskaya T.A., Esmagambetov I.B., Favorskaya I.A., Zrelkin D.I., Voronina D.V., Shcherbinin D.N., Semikhin A.S., Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 2021; 397(10275):671–681. https://doi.org/10.1016/S0140-6736(21)00234-8 2. Eskendirova Z.M., Mutusheva A.T., Dukaeva Zh.K., Solopenko M.Zh., Kalibaeva N.K. [Coronavirus infection in people vaccinated against COVID-19]. Valeology: Health – Illness – Recovery (Kazakhstan) 2021; (3):76‒77 (in Russian). 3. Linets Yu.P., Artyukhov S.V., Kazantsev A.N., Zaitseva T.Y., Roshkovskaya L.V., Sokolova S.V., Chikin A.Y., Yenova G.K., Kondakov S.B. COVID-19 Course in Vaccinated Patients. Russian Sklifosovsky Journal "Emergency Medical Care". 2021; 10(4):636‒641. https://doi.org/10.23934/2223-9022-2021-10-4-636-641 4. Borisova A.A., Popova N.D., Kychkina A.I., Rozhina A.A., Fedulova A.G. [Epidemiological characteristics of the dynamics of a new coronavirus infection (COVID-19) in the Republic of Sakha (Yakutia)]. International Research Journal 2022; 1-2 (115):84‒87 (in Russian). https://doi.org/10.23670/IRJ.2022.115.1.057 5. Kolobukhina L.V., Burgasova O.A., Kruzhkova I.S., Bakalin V.V., Generalova L.V., Shagaev A.V., Ogarkova D.A., Nikiforova M.A., Vasina D.V., Gushchin V.A., Smetanina S.V. Assessment of COVID-19 clinical course in patients vaccinated with Sputnik V, SARS-CoV-2 S protein RBD domain variation and serum virus neutralizing activity. Bulletin of Russian State Medical University 2021; (5):62‒70. https://doi.org/10.24075/brsmu.2021.046
|
|